Lea Ann Dailey
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 9
- Biomaterials 14
- Nanoparticle-Based Drug Delivery 9
- Co-authors
- Thomas KisselBen ForbesMatthias WittmarMark GreenThomas SchmehlTobias GesslerWerner SeegerGary P. Martin
- Journals
- Journal of Controlled Release (11 papers)Journal of Materials Chemistry B (5 papers)European Journal of Pharmaceutics and Biopharmaceutics (5 papers)Pharmaceutical Research (4 papers)ACS Applied Materials & Interfaces (4 papers)
- Partner nations
- United KingdomGermanyAustria
In The Last Decade
Lea Ann Dailey
90 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 134
- Pharmaceutical Science 546
- Biomaterials 456
- Pulmonary and Respiratory Medicine 872
- Biomedical Engineering 565
- Materials Chemistry 548
Countries citing papers authored by Lea Ann Dailey
This map shows the geographic impact of Lea Ann Dailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lea Ann Dailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lea Ann Dailey more than expected).
Fields of papers citing papers by Lea Ann Dailey
This network shows the impact of papers produced by Lea Ann Dailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lea Ann Dailey. The network helps show where Lea Ann Dailey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lea Ann Dailey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 16 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 13 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 8 | |
| 13 | 2021 | 4 | |
| 14 | 2021 | 30 | |
| 15 | 2020 | 4 | |
| 16 | 2019 | 12 | |
| 17 | 2017 | 30 | |
| 18 | 2017 | 12 | |
| 19 | 2015 | 81 | |
| 20 | 2003 | 72 |
About Lea Ann Dailey
Lea Ann Dailey is a scholar working on Pharmaceutical Science, Biomaterials, Pulmonary and Respiratory Medicine, Pollution and Materials Chemistry, having authored 95 papers that have together received 2.5k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (31 papers), Nanoplatforms for cancer theranostics (15 papers), Luminescence and Fluorescent Materials (13 papers), Nanoparticle-Based Drug Delivery (9 papers), Advanced Drug Delivery Systems (9 papers), Lipid Membrane Structure and Behavior (9 papers), Microplastics and Plastic Pollution (7 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Pharmaceutical Science (546 citations), Biomaterials (456 citations), Pulmonary and Respiratory Medicine (872 citations), Biomedical Engineering (565 citations) and Materials Chemistry (548 citations). Lea Ann Dailey has collaborated with scholars based in United Kingdom, Germany and Austria. Frequent co-authors include Thomas Kissel, Ben Forbes, Matthias Wittmar, Mark Green, Thomas Schmehl, Tobias Gessler, Werner Seeger, Gary P. Martin, Thais Fedatto Abelha and Peter Imming. Their work appears in journals such as Journal of Controlled Release, Journal of Materials Chemistry B, European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutical Research and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.